OXB-301

N/A

Report date: 2024/04/19 20:00:31

Base Information

Drug NameOXB-301
Drug Alias Name5T4肿瘤疫苗 - 牛津生物医药5T4 cancer vaccineOBA 1 cancer vaccineModified vaccinia Ankara 5T4Recombinant modified vaccinia Ankara 5T4 vaccine +[12] 
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionT lymphocytes stimulantsTrophoblast glycoprotein modulators
TargetsTrophoblast glycoprotein
Therapy Area/IndicationsHormone-Resistant Prostate NeoplasmsProstatic NeoplasmsFallopian Tube Neoplasms +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUkrainePoland +[10] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOxford Biomedica
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOxford BiomedicaUniversity College LondonNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsHormone-Resistant Prostate NeoplasmsProstatic NeoplasmsFallopian Tube Neoplasms +[8] 

Other Information

ATC CodeN/A
Related LinksN/A